ToxStrategies

Innovative Solutions / Sound Science

Newsletter Signup
  • Services
    • Air Quality
    • Animal Feed and Pet Food
    • Bioaccessibility and Relative Bioavailability of Metals
    • Biopharmaceuticals / Pharmaceuticals
    • Cannabinoid and Industrial Hemp Safety
    • Causation Analysis
    • Coal Combustion Residuals
    • Computational Toxicology
    • Cosmetics & Personal Care Products Qualifications
    • Cumulative Impact Assessment
    • Developmental, Reproductive, and Juvenile Toxicity
    • Endocrine Disruption Evaluation
    • Environmental Liability Cost Analysis
    • Environmental Sciences
    • Epidemiology and Biostatistics
    • Epigenetics
    • Exposure Assessment
    • Food Defense and Intentional Adulteration
    • Food and Supplement Safety 
    • Food Safety and Preventive Controls
    • Food Safety Modernization Act (FSMA)
    • Foreign Supplier Verification Program
    • GHS: OSHA and REACH/CLP
    • Health Economics and Outcomes Research (HEOR) Overview
    • Industrial Hygiene
    • Medical Devices Qualifications
    • Neurotoxicology and Neuroscience
    • New Approach Methods (NAMs) and Alternatives to Animal Testing
    • Ocular Toxicology
    • PBPK and IVIVE
    • Per-and Polyfluoralkyl Substances (PFAS)
    • Pesticides
    • Process Authority and Microbial Risk Assessment
    • Proposition 65
    • Quantitative Structure-Activity Relationship (QSAR) Modeling
    • Radiation Risk Assessment and Management
    • Risk Assessment
    • Risk Communication
    • Sustainability and Global Product Stewardship
    • Systematic Reviews and Evidence-Based Toxicology
    • Toxicology
    • Toxicology Monographs
    • TSCA
  • Publications
    • Abstracts and Presentations
    • Book Chapters
    • Manuscripts
    • Protocol Registrations
  • People
  • Careers
  • Company
    • Our Mission
    • Latest News
    • Locations
    • People
    • Newsletter Signup
    • Careers
    • Divisions
    • Contact Us
  • Publications
  • ToxStrategies Consulting Services
  • People
  • Our Company
  • Careers
  • Locations
  • Newsletter Signup
  • Latest News
  • Divisions
  • Contact Us

Author Archives: cmccormick

Post navigation

← Older posts
Newer posts →

HEORStrategies’ Dr. Naomi Sacks is a Co-Author on a Study of Trends in Myasthenia Gravis Hospitalizations and Mortality 

January 18, 2024 by cmccormick

Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study on myasthenia gravis (MG) just published in the journal Neurology. MG… read more

Posted in Latest News |

ToxStrategies’ Scientists Publish Data Supporting Safety of Dietary Nitrate in Pigs

January 17, 2024 by cmccormick

ToxStrategies’ scientists Amy Sheppard and Jennifer van de Ligt collaborated with a team of industry scientists from Cargill to evaluate the safety of… read more

Posted in Latest News |

ToxStrategies at IPPE 2024 – Atlanta, GA (Booth #A215)

January 16, 2024 by cmccormick

ToxStrategies will be attending and exhibiting at the International Production & Processing Expo (IPPE) in Atlanta, GA from January 30 to February 1,… read more

Posted in Latest News |

EPA Begins TSCA Prioritization Process for Five Chemicals

January 16, 2024 by cmccormick

The US Environmental Protection Agency (EPA) has announced that it is beginning the 12-month process to prioritize five additional chemicals for risk evaluation… read more

Posted in Latest News |

New Publication Assessing Risk from Perfluorocarboxylic Acids in Fluorinated HDPE Containers

January 10, 2024 by cmccormick

ToxStrategies scientists LeeAnn Racz, Alison Gauthier, Jennifer Bare, Melissa Heintz, David Feifarek, Stephanie Kennedy, and Julie Panko assessed the risk of human and… read more

Posted in Latest News |

ToxStrategies’ Scientists Publish Cobalt Bioavailability Comparison Study

January 9, 2024 by cmccormick

ToxStrategies’ scientist Jennifer van de Ligt collaborated with a team of industry scientists to compare tissue cobalt concentrations and growth performance of beef… read more

Posted in Latest News |

HEORStrategies’ Dr. Naomi Sacks is a co-author on a large-scale study of obesity and overweight in the United States

December 21, 2023 by cmccormick

Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study just published in the journal Obesity Science and Practice. Using national… read more

Posted in Latest News |

FDA Issues Updated Instructions for Serious Adverse Event Reporting for Cosmetic Products and Publishes Updated Structured Product Labeling (SPL)

December 18, 2023 by cmccormick

On December 14, 2023, the U.S. Food and Drug Administration provided an update related to serious adverse event reporting mandated by the Modernization… read more

Posted in Latest News |

Post navigation

← Older posts
Newer posts →

Our Publications

published
Click here to see some of our recently published articles and abstracts.

COPYRIGHT ©2025 ToxStrategies, a BlueRidge Life Science Company All Rights Reserved.  |  Privacy Policy  |  Terms of Use